Startup Scouting for Corporations
|
See BrightInsight's full profile BOOK A DEMO |
| Headquarters United States |
Founded Year 2020 |
Total Funding
$166.0M |
Employees
201 - 500 |
Status Active |
About BrightInsightBrightInsight provides the leading global regulated digital health platform for biopharma and medtech. |
HeadquartersUnited States |
General Information on BrightInsight
| Brand name | BrightInsight |
| Company name | BrightInsight Inc. |
| Website | https://brightinsight.com/ |
| Founded year | 2020 |
| Employees | 201 - 500 |
| Founding team | |
| Contact | [email protected] |
|
Find startup solutions in your specific business context The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
|
BOOK A DEMO |
Recent News and Activity about BrightInsight |
|
HIT Consultant News
•
17.06.2022
BrightInsight Launches Digital Disease Management Solution for BiopharmaWhat You Should Know: – BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions launches its Disease Management Solution. – This configurable suite of digital applications includes a Patient App, Analytics Dashboards and Healthcare Provider Interfaces. The Disease Management Solution, built on the compliant BrightInsight® Platform on Google Cloud, meets biopharma and medtech ... 
|
|
Plato Data Intelligence, Plato Vertical Search
•
12.06.2022
[BrightInsight In Pharmaphorum] How Digital Is Transforming The Commercial Leader’s Role In BiopharmaThe digital revolution has already reshaped the commercial engine of biopharma companies. 
|
|
The Bakersfield
•
17.05.2022
BrightInsight Adds Biopharma Technology and Digital Health Expert, Karl Hick, to Advisory Council BrightInsight - (GLOBE NEWSWIRE) May 17, 2022 41 min agodigital health solutions, announced today the appointment of Karl Hick , former Chief Digital and Information Officer of Takeda Pharmaceuticals, to the BrightInsight Advisory Council. Mr. Hick joins this group of esteemed industry experts working with the BrightInsight Leadership Team to advance the company's vision to transform patient outcomes globally through the power of digital technology. Mr. Hick joins as BrightInsight continues to ... 
|
|
Yahoo! Finance
•
17.05.2022
BrightInsight Adds Biopharma Technology and Digital Health Expert, Karl Hick, to Advisory CouncilKarl Hick Joins BrightInsight Advisory Council SAN JOSE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Karl Hick , former Chief Digital and Information Officer of Takeda Pharmaceuticals, to the BrightInsight Advisory Council. Mr. Hick joins this group of esteemed industry experts working with ... 
|
|
Open PR
•
20.04.2022
Software as a Medical Device Market Size 2022 to 2030 | Major Players - Inzentiz,CompliancePath,Zhlke Group,Cambridge Consultants Inc,S3 Connected Health,Pro4People Sp. Z.o.o,Velentium LLC,Tietronix Software, Inc.,Phillips-Medisize,BrightInsight, Inc.,JabSoftware as a medical device market Software as a medical device market is defined as a software solution used for one or more medical purposes without the software actually being a part of any medical hardware. These solutions can be used across a large range of technology platforms, including medical device, commercial "off-the-shelf" platforms, virtual networks, and others. The unique features of these devices that help them act more than a ... 
|
|
CIO Review
•
01.04.2022
BrightInsight and UCBPartner to Build Digital Care Solutions for Rare DiseasesSAN JOSE, Calif. – (Globe Newswire) BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today a partnership withthe global biopharmaceutical company, UCB, to develop and bring to market a digital disease management solution for patients with rare diseases.UCB selected the proven, scalable Brightinsight® Platform to accelerate time to market for UCB’s digital care ... |
|
CIO Review
•
01.04.2022
BrightInsight Announces Partnershipwith Sanofi to Bring to Market aNext GenerationDigital Companion ApplicationSAN JOSE, Calif. – (Globe Newswire) BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today a partnership with Sanofi, a global biopharmaceutical company focused on human health, to bring to market a next generation digital companion application for one of Sanofi’s products. The BrightInsight® Platform has beenselected to serve as the underlying infrastructure to ... |
|
NS Medical Devices
•
12.03.2022
BrightInsight and UCB Partner to Build Digital Care Solutions for Rare DiseasesBrightInsight teams up with UCB to build digital care solutions for rare diseases. (Credit: ckstockphoto/Pixabay) BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today a partnership with the global biopharmaceutical company, UCB, to develop and bring to market a digital disease management solution for patients with rare diseases. UCB selected the proven, ... 
|
|
Bionewsfeeds
•
10.03.2022
Mobile App for MG Patients Being Developed by BrightInsight, UCBmyasthenia gravis (MG) manage their disease and improve their care and clinical outcomes. “MG is a rare, challenging and unpredictable disease, and innovation is urgently needed to better support those living with it. This partnership takes us one step forward in our goal to harness digital solutions and the latest AI [artificial… You must be logged in to read/download the full post. |
|
Myasthenia gravis news
•
10.03.2022
New Mobile App for MG Patients in Development by BrightInsight, UCB“MG is a rare, challenging and unpredictable disease, and innovation is urgently needed to better support those living with it. This partnership takes us one step forward in our goal to harness digital solutions and the latest AI [artificial intelligence] technologies to better serve patients and potentially improve their care,” Colin Lake, vice president and head of digital business transformation neurology at UCB, said in a press release. The ... 
|
Footer
About INNOSPOT
